You are here

  • Home
  • Archive
  • Volume 72, Issue 5
  • eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese

Citation Tools

Article menu
Download PDFPDF
Electronic pages
Correspondence response
eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Triantafyllou A, Pyrpasopoulou A, Anyfanti P, et al
eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese
Annals of the Rheumatic Diseases 2013;72:e7.